nature.com search

Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

Nature

Search
My Account Login

nature
search

Search

advanced

where the list of authors contains where the title contains

Refine your results by…

volume

start page / article no.

Filters

Filter By:

Article type

Check one or more article types to show results from those article types only.

Research (3)
Amendments and Corrections (2)

Journal

Check one or more journals to show results from those journals only.

Nature (5)

Choose more journals

Subject Check one or more subjects to show results from those subjects only.

Chemotherapy (2)
Prognostic markers (2)
Tumour immunology (2)

Date

Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
In the last year
Last 2 years
Last 5 years

Custom date range

Sort by Relevance

Choose a way to sort results.

Relevance
Date — most recent
Date — oldest first

Loading Filters

Showing 1–5 of 5 results

Loading Filters

Amendments and Corrections | 6 April 2016
Correction: Corrigendum: Inactivation of PI(3)K p110δ breaks regulatory T-cell-mediated immune tolerance to cancer
- Khaled Ali
- , Dalya R. Soond
- , Roberto Piñeiro
- , Thorsten Hagemann
- , Wayne Pearce
- , Ee Lyn Lim
- , Hicham Bouabe
- , Cheryl L. Scudamore
- , Timothy Hancox
- , Heather Maecker
- , Lori Friedman
- , Martin Turner
- , Klaus Okkenhaug
- & Bart Vanhaesebroeck
Nature 535 , 580–580

Rights & permissionsfor article Correction: Corrigendum: Inactivation of PI(3)K p110δ breaks regulatory T-cell-mediated immune tolerance to cancer . Opens in a new window.
Research | 11 June 2014
Inactivation of PI(3)K p110δ breaks regulatory T-cell-mediated immune tolerance to cancer
- Khaled Ali
- , Dalya R. Soond
- , Roberto Piñeiro
- , Thorsten Hagemann
- , Wayne Pearce
- , Ee Lyn Lim
- , Hicham Bouabe
- , Cheryl L. Scudamore
- , Timothy Hancox
- , Heather Maecker
- , Lori Friedman
- , Martin Turner
- , Klaus Okkenhaug
- & Bart Vanhaesebroeck
Nature 510 , 407–411

Rights & permissionsfor article Inactivation of PI(3)K p110δ breaks regulatory T-cell-mediated immune tolerance to cancer . Opens in a new window.
Amendments and Corrections | 15 June 2011
Erratum: Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7
- Ingrid E. Wertz
- , Saritha Kusam
- , Cynthia Lam
- , Toru Okamoto
- , Wendy Sandoval
- , Daniel J. Anderson
- , Elizabeth Helgason
- , James A. Ernst
- , Mike Eby
- , Jinfeng Liu
- , Lisa D. Belmont
- , Joshua S. Kaminker
- , Karen M. O’Rourke
- , Kanan Pujara
- , Pawan Bir Kohli
- , Adam R. Johnson
- , Mark L. Chiu
- , Jennie R. Lill
- , Peter K. Jackson
- , Wayne J. Fairbrother
- , Somasekar Seshagiri
- , Mary J. C. Ludlam
- , Kevin G. Leong
- , Erin C. Dueber
- , Heather Maecker
- , David C. S. Huang
- & Vishva M. Dixit
Nature 475 , 122–122

Rights & permissionsfor article Erratum: Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7 . Opens in a new window.
Research | 2 March 2011
Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7
- Ingrid E. Wertz
- , Saritha Kusam
- , Cynthia Lam
- , Toru Okamoto
- , Wendy Sandoval
- , Daniel J. Anderson
- , Elizabeth Helgason
- , James A. Ernst
- , Mike Eby
- , Jinfeng Liu
- , Lisa D. Belmont
- , Joshua S. Kaminker
- , Karen M. O’Rourke
- , Kanan Pujara
- , Pawan Bir Kohli
- , Adam R. Johnson
- , Mark L. Chiu
- , Jennie R. Lill
- , Peter K. Jackson
- , Wayne J. Fairbrother
- , Somasekar Seshagiri
- , Mary J. C. Ludlam
- , Kevin G. Leong
- , Erin C. Dueber
- , Heather Maecker
- , David C. S. Huang
- & Vishva M. Dixit
Nature 471 , 110–114

Rights & permissionsfor article Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7 . Opens in a new window.
Research | 20 December 2009
Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival
- Martin Schwickart
- , XiaoDong Huang
- , Jennie R. Lill
- , Jinfeng Liu
- , Ronald Ferrando
- , Dorothy M. French
- , Heather Maecker
- , Karen O’Rourke
- , Fernando Bazan
- , Jeffrey Eastham-Anderson
- , Peng Yue
- , David Dornan
- , David C. S. Huang
- & Vishva M. Dixit
Nature 463 , 103–107

Rights & permissionsfor article Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival . Opens in a new window.

Advertisement

Search

Article Search

Advanced search

Quick links

Explore articles by subject
Find a job
Guide to authors
Editorial policies

nature.com sitemap

About us
Press releases
Press office
Contact us

Discover content

Journals A-Z
Articles by subject
Nano
Protocol Exchange
Nature Index

Publish with us

Guide to Authors
Guide to Referees
Editorial policies
Open access
Reprints & permissions

Researcher services

Research data
Language editing
Scientific editing
Nature Masterclasses
Nature Research Academies

Libraries & institutions

Librarian service & tools
Librarian portal
Open research
Recommend to library

Advertising & partnerships

Advertising
Partnerships & Services
Media kits
Branded content

Career development

Nature Careers
Nature Conferences
Nature events

Regional websites

Nature China
Nature India
Nature Japan
Nature Korea
Nature Middle East

Legal & Privacy

Privacy Policy
Use of cookies
Manage cookies/Do not sell my data
Legal notice
Accessibility statement
Terms & Conditions
California Privacy Statement

© 2021 Springer Nature Limited